Skip to main content
Clinical Trials/NL-OMON22013
NL-OMON22013RecruitingNot Applicable

Phase shift in ADHD of sleep and appetite

Marc Blom, PhD, Director PsyQ The Hague0 sites51 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
51

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Age between 18 and 55 years old
  • - Diagnosis ADHD

Exclusion Criteria

  • - Psychotic illness
  • - Untreated mood disorder

Investigators

Sponsor
Marc Blom, PhD, Director PsyQ The Hague

Similar Trials

Active, not recruiting
Phase 1
Study on the best treatment for the Delayed Sleep Phase Syndrome in adults with ADHD.Delayed Sleep Phase Syndrome (DSPS) in adult patients with Attention-Deficit/Hyperctivity Disorder (ADHD)MedDRA version: 16.1Level: LLTClassification code 10064104Term: ADHDSystem Organ Class: 100000004873MedDRA version: 16.1Level: PTClassification code 10012209Term: Delayed sleep phaseSystem Organ Class: 10029205 - Nervous system disorders
EUCTR2012-000320-18-NLParnassia Bavo Groep - PsyQ51
Completed
Phase 4
Phase shift in adult ADHD of sleep and apetite.
NL-OMON46908Parnassia Bavo Groep (Den Haag)51
Recruiting
Phase 2
Attention Defficity Hyperactivity Disorder and fMRI neurofeedback: A randomized controlled trial on the effects of self-modulating anterior cingulate cortex activation levels.Attention Deficit Hyperactivity Disorder
NL-OMON37512niversitair Medisch Centrum Sint Radboud
Active, not recruiting
Not Applicable
Attention Deficit Hyperactivity Disorder (ADHD) and opioid maintenance therapy.A randomized, placebo-controlled study of the efficacy of atomoxetine for treating adult ADHD in patients receiving opioid maintenance therapyPatients will be recruited from out-patient clinics treating opioid dependent patients with buprenorphine or methadone maintenance therapy. Patients will be screened for ADHD symptoms. Based on the screen results, patients will undergo medical and psychiatric assessment to identify those meeting the criteria for adult ADHD. Patients diagnosed with comorbid ADHD and opioid dependence will then be randomized into atomoxetine and placebo study groups.MedDRA version: 12.1Level: LLTClassification code 10064104Term: ADHD
EUCTR2010-019981-94-FIHUS/ Neuropsykiatrian poliklinikka30
Completed
Not Applicable
Are sleep onset problems in adults with ADHD related to a disruption of the circadian rhythm?
NL-OMON29883Parnassia (Den Haag)40
Investigating the best treatment for the... | Clinical Trial